Prediabetes, depressive and anxiety symptoms, and risk of type 2 diabetes: A community-based cohort study

Journal of Psychosomatic Research

Volumn 89, Issue , 2016, Pages 85-90

  Deschênes, Sonya S ^a,b   Burns, Rachel J ^a,b   Graham, Eva ^a,b   Schmitz, Norbert ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Anxiety; Cohort study; Depression; Prediabetes; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; RISK FACTOR; SECONDARY ANALYSIS; SMOKING; ANXIETY; COHORT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PREDIABETIC STATE; PSYCHOLOGY;

ADULT; AGED; ANXIETY; COHORT STUDIES; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 84984830220     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2016.08.011     Document Type: Article

References (41)

1. [1] Collaborators GBoDS. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet 386 (2015), 743–800.
2. [2] Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 94 (2011), 311–321.
3. [3] Bonora, E., Kiechl, S., Mayr, A., Zoppini, G., Targher, G., Bonadonna, R.C., et al. High-normal HbA1c is a strong predictor of type 2 diabetes in the general population. Diabetes Care 34 (2011), 1038–1040.
4. [4] Mainous, A.G., Tanner, R.J., Baker, R., Zayas, C.E., Harle, C.A., Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open, 4, 2014, e005002.
5. [5] Nathan, D.M., Davidson, M.B., Defronzo, R.A., Heine, R.J., Henry, R.R., Pratley, R., et al. Impaired fasting glucose and impaired glucose tolerance implications for care. Diabetes Care 30 (2007), 753–759.
6. [6] Tabak, A.G., Herder, C., Rathmann, W., Brunner, E.J., Kivimaki, M., Prediabetes: a high-risk state for diabetes development. Lancet 379 (2012), 2279–2290.
7. [7] Knowler, W.C., Fowler, S.E., Hamman, R.F., Christophi, C.A., Hoffman, H.J., Brenneman, A.T., et al. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet 374 (2009), 1677–1686.
8. [8] Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001), 1343–1350.
9. [9] Strine, T.W., Mokdad, A.H., Dube, S.R., Balluz, L.S., Gonzalez, O., Berry, J.T., et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen. Hosp. Psychiatry 30 (2008), 127–137.
10. [10] Mezuk, B., Eaton, W.W., Albrecht, S., Golden, S.H., Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31 (2008), 2383–2390.
11. [11] Pouwer, F., Beekman, A.T., Nijpels, G., Dekker, J.M., Snoek, F.J., Kostense, P.J., et al. Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus: results from a community-based study. Diabetologia 46 (2003), 892–898.
12. [12] Knol, M.J., Twisk, J.W., Beekman, A.T., Heine, R.J., Snoek, F.J., Pouwer, F., Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49 (2006), 837–845.
13. [13] Engum, A., The role of depression and anxiety in onset of diabetes in a large population-based study. J. Psychosom. Res. 62 (2007), 31–38.
14. [14] Eriksson, A.K., Ekbom, A., Granath, F., Hilding, A., Efendic, S., Östenson, C.G., Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet. Med. 25 (2008), 834–842.
15. [15] Virtanen, M., Ferrie, J.E., Tabak, A.G., Akbaraly, T.N., Vahtera, J., Singh-Manoux, A., et al. Psychological distress and incidence of type 2 diabetes in high-risk and low-risk populations: the Whitehall II cohort study. Diabetes Care 37 (2014), 2091–2097.
16. [16] Pouwer, F., Kupper, N., Adriaanse, M.C., Does emotional stress cause type 2 diabetes mellitus? A review from the European depression in diabetes (EDID) research consortium. Discov. Med. 9 (2010), 112–118.
17. [17] Meurs, M., Roest, A.M., Wolffenbuttel, B.H., Stolk, R.P., de Jonge, P., Rosmalen, J.G., Association of depressive and anxiety disorders with diagnosed versus undiagnosed diabetes: An epidemiological study of 90,686 participants. Psychosom. Med. 78 (2016), 233–241.
18. [18] Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 289 (2003), 3095–3105.
19. [19] Schmitz, N., Deschenes, S.S., Burns, R.J., Smith, K.J., Lesage, A., Strychar, I., et al. Depression and risk of type 2 diabetes: the potential role of metabolic factors. Mol. Psychiatry, 2016.
20. [20] Awadalla, P., Boileau, C., Payette, Y., Idaghdour, Y., Goulet, J.-P., Knoppers, B., et al. Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics. Int. J. Epidemiol. 42 (2013), 1285–1299.
21. [21] Lamers, F., Jonkers, C.C.M., Bosma, H., Penninx, B., Knottnerus, J.A., van Eijk, J.T.M., Summed score of the patient health questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J. Clin. Epidemiol. 61 (2008), 679–687.
22. [22] Kroenke, K., Spitzer, R.L., Williams, J.B., The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 16 (2001), 606–613.
23. [23] Association AD, Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (2010), S62–S69.
24. [24] Zhang, X., Gregg, E.W., Williamson, D.F., Barker, L.E., Thomas, W., Bullard, K.M., et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 33 (2010), 1665–1673.
25. [25] Eaton, W.W., Hall, A.L., Macdonald, R., McKibben, J., Case identification in psychiatric epidemiology: a review. Int. Rev. Psychiatry (Abingdon, England) 19 (2007), 497–507.
26. [26] Manea, L., Gilbody, S., McMillan, D., Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): a meta-analysis. CMAJ 184 (2012), E191–E196.
27. [27] Spitzer, R.L., Kroenke, K., Williams, J.B., Lowe, B., A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 166 (2006), 1092–1097.
28. [28] Hosmer, D.W., Lemeshow, S., Confidence interval estimation of interaction. Epidemiology 3 (1992), 452–456.
29. [29] Hu, F.B., Manson, J.E., Stampfer, M.J., Colditz, G., Liu, S., Solomon, C.G., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 345 (2001), 790–797.
30. [30] Bassuk, S.S., Manson, J.E., Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J. Appl. Physiol. 99 (2005), 1193–1204.
31. [31] Da Silva, M.A., Singh-Manoux, A., Brunner, E.J., Kaffashian, S., Shipley, M.J., Kivimäki, M., et al. Bidirectional association between physical activity and symptoms of anxiety and depression: the Whitehall II study. Eur. J. Epidemiol. 27 (2012), 537–546.
32. [32] Committee. IR, Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ)–Short and Long Forms. 2005.
33. [33] Deuschle, M., Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr. Opin. Psychiatry 26 (2013), 60–65.
34. [34] Toshihiro, M., Saito, K., Takikawa, S., Takebe, N., Onoda, T., Satoh, J., Psychosocial factors are independent risk factors for the development of type 2 diabetes in Japanese workers with impaired fasting glucose and/or impaired glucose tolerance. Diabet. Med. 25 (2008), 1211–1217.
35. [35] Au, B., Smith, K.J., Gariepy, G., Schmitz, N., C-reactive protein, depressive symptoms, and risk of diabetes: results from the English longitudinal study of ageing (ELSA). J. Psychosom. Res. 77 (2014), 180–186.
36. [36] Tully, P.J., Cosh, S.M., Baune, B.T., A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease. Psychol. Health Med. 18 (2013), 627–644.
37. [37] Heraclides, A.M., Chandola, T., Witte, D.R., Brunner, E.J., Work stress, obesity and the risk of type 2 diabetes: gender-specific bidirectional effect in the Whitehall II study. Obesity 20 (2012), 428–433.
38. [38] Rosmond, R., Björntorp, P., The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J. Intern. Med. 247 (2000), 188–197.
39. [39] Herman, W.H., Hoerger, T.J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann. Intern. Med. 142 (2005), 323–332.
40. [40] Eddy, D.M., Schlessinger, L., Kahn, R., Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann. Intern. Med. 143 (2005), 251–264.
41. [41] Deschênes, S.S., Burns, R.J., Schmitz, N., Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian community health survey—Mental health (CCHS-MH). J. Psychosom. Res. 78 (2015), 137–142.